(19)
(11) EP 1 919 916 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
30.04.2014 Bulletin 2014/18

(45) Mention of the grant of the patent:
03.04.2013 Bulletin 2013/14

(21) Application number: 06789951.8

(22) Date of filing: 23.08.2006
(51) International Patent Classification (IPC): 
C07D 487/04(2006.01)
A61K 31/50(2006.01)
 C07D 471/04(2006.01)
A61P 35/00(2006.01)
(86) International application number:
PCT/US2006/032912
(87) International publication number:
WO 2007/024945 (01.03.2007 Gazette 2007/09)

(54)

CONDENSED IMIDAZOLO DERIVATIVES FOR THE INHIBITION OF ALDOSTERONE SYNTHASE AND AROMATASE

KONDENSIERTE IMIDAZOLODERIVATE FÜR DIE HEMMUNG VON ALDOSTERON-SYNTHASE UND AROMATASE

DERIVES IMIDAZOLO CONDENSES UTILISES POUR INHIBER L'ALDOSTERONE SYNTHASE ET L'AROMATASE

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
Designated Extension States:
BA HR MK

(30) Priority: 25.08.2005 US 711442 P

(43) Date of publication of application:
14.05.2008 Bulletin 2008/20

(60) Divisional application:
10175231.9 / 2270011
10175269.9 / 2256118

(73) Proprietors:
  • Novartis AG
    4056 Basel (CH)
    Designated Contracting States:
    BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR 
  • Novartis Pharma GmbH
    1230 Wien (AT)
    Designated Contracting States:
    AT 

(72) Inventors:
  • KSANDER, Gary Michael
    Amherst, New Hampshire 03031 (US)
  • MEREDITH, Erik
    Hudson, Massachusetts 01749 (US)
  • MONOVICH, Lauren G.
    Belmont, Massachusetts 02478 (US)
  • PAPILLON, Julien
    Somerville, Massachusetts 02144 (US)
  • FIROOZNIA, Fariborz
    Florham Park, New Jersey 07932 (US)
  • HU, Qi-Ying
    Needham, Massachusetts 02492 (US)

(74) Representative: Pfister-Fu, Yixin et al
Novartis Pharma AG Patent Department
4002 Basel
4002 Basel (CH)


(56) References cited: : 
EP-A2- 0 426 225
WO-A-2004/046145
 WO-A-93/15079
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).